Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA.

[1]  S. Nordling,et al.  Tumour-associated trypsin inhibitor, TATI, in patients with pancreatic cancer, pancreatitis and benign biliary diseases. , 1986, British Journal of Cancer.

[2]  G. Fleuren,et al.  The tumor marker CA 125 is a common constituent of normal cervical mucus. , 1986, American journal of obstetrics and gynecology.

[3]  Kerstin,et al.  Two apparent human endothelial cell growth factors from human hepatoma cells are tumor-associated proteinase inhibitors. , 1986, The Journal of biological chemistry.

[4]  M. Maeyama,et al.  Biochemical and immunohistochemical studies on carcinoembryonic antigen of ovarian mucinous and serous tumors. , 1986, Gynecologic oncology.

[5]  U. Stenman,et al.  Pancreatic secretory trypsin inhibitor-like immunoreactivity in pancreatectomized patients. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[6]  M. Ogawa,et al.  Elevation of serum pancreatic secretory trypsin inhibitor (PSTI) in patients with serious injury. , 1985, Research communications in chemical pathology and pharmacology.

[7]  T. Koivula,et al.  Tumour‐associated antigen CA 125 in patients with ovarian cancer , 1985, British journal of obstetrics and gynaecology.

[8]  M. Huhtala.  Demonstration of a new acrosin inhibitor in human seminal plasma. , 1984, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[9]  R. Bast,et al.  Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. , 1984, Cancer research.

[10]  R. Bast,et al.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. , 1983, The New England journal of medicine.

[11]  U. Stenman,et al.  Excretion of a tumor‐associated trypsin inhibitor (TATI) in urine of patients with gynecological malignancy , 1983, International journal of cancer.

[12]  R. Bast,et al.  Tissue Distribution of a Coelomic- Epithelium‐Related Antigen Recognized by the Monoclonal Antibody OC125 , 1983, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[13]  L. Liotta,et al.  Tumor invasion and the extracellular matrix. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[14]  U. Stenman,et al.  Purification and characterization of a tumor-associated trypsin inhibitor from the urine of a patient with ovarian cancer. , 1982, The Journal of biological chemistry.

[15]  U. Stenman,et al.  Immunochemical demonstration of an ovarian cancer‐associated urinary peptide , 1982, International journal of cancer.

[16]  R. Bast,et al.  Reactivity of a monoclonal antibody with human ovarian carcinoma. , 1981, The Journal of clinical investigation.

[17]  P. Burtin,et al.  Antigens common to human ovarian mucinous cyst fluid and gastric mucosa. , 1977, British Journal of Cancer.

[18]  D. Goldenberg,et al.  A study of cyst fluid and plasma carcinoembryonic antigen in patients with cystic ovarian neoplasms. , 1975, Cancer research.

[19]  R. Nairn,et al.  Intestinal Antigenicity of Ovarian Mucinous Cystadenomas , 1971, British Journal of Cancer.

[20]  L. A. Kazal,et al.  Isolation of a crystalline trypsin inhibitor-anticoagulant protein from pancreas. , 1948, Journal of the American Chemical Society.

[21]  J. Knight,et al.  Comparison of biochemical markers between benign and malignant ovarian cysts. , 1986, Clinical physiology and biochemistry.

[22]  M. Cauchi,et al.  Oncofetal antigens in ovarian cyst fluids. , 1984, Gynecologic and obstetric investigation.